Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.9B | 8.6B | 8.0B | 9.2B |
Cost of revenue | 6.1B | 6.7B | 6.3B | 8.0B |
Gross profit | 1.8B | 1.9B | 1.7B | 1.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 1.3B | 1.1B | 1.5B |
Other operating expenses | 956M | 39M | 55M | 184M |
Operating income | 503M | 678M | 605M | -268M |
Non operating interest income | ||||
Income | 13M | — | — | 12M |
Expense | 185M | — | — | 257M |
Other income expense | — | — | — | — |
Pretax income | 305M | 474M | 362M | -542M |
Tax provision | 89M | 87M | 106M | 129M |
Net income | 216M | 388M | 256M | -671M |
Basic EPS | 0.1 | 0.2 | 0.1 | -0.4 |
Diluted EPS | 0.1 | 0.2 | 0.1 | -0.4 |
Basic average shares | 1.7B | 1.7B | 1.7B | 1.7B |
Diluted average shares | 1.7B | 1.7B | 1.7B | 1.7B |
EBITDA | 929M | 678M | 605M | -285M |
Net income from continuing op. | 305M | 474M | 362M | -542M |
Minority interests | -21M | -60M | -29M | -51M |
Preferred stock dividends | 0 | 0 | 0 | 0 |